Novo Holdings — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
HealthtechJacksonville, US
Nathan W. Eastman(Chief Financial Officer, Treasurer)Christopher Hunter(Director)Steve Betts(Director)Earnie Franklin(Director)Aaron Gani(Director)Carl McDonald(Director)
Board seatAbhijeet Lele· per SEC Form D
Co-investorsFrancisco Partners
Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs.
BiotechCircular EconomyCleantechClimate TechNew MaterialsSan Diego, US
Christophe Schilling(Co-founder (former CEO))Bernhard Palsson(Co-founder)Thomas McDonald(Executive Officer)Carlos A. Cabrera(Executive Chairman)John G. Gugel(Chief Executive Officer)Tom McDonald(SVP, Finance & Chief Financial Officer)
Board seatAnders Bendsen Spohr· per SEC Form D · $119.1M raise · filed Aug 2021
Co-investorsVantagePoint Capital PartnersCasdin Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.